Which cells are affected by cancer?
A. Only red blood cells
B. Only neurons
C. Any type of body cell
D. Only skin cells
#cells #cancercells #cancer #oncology ... Continue to:
@allscientifical.bsky.social
@allscientifical.bsky.socialWhich cells are affected by cancer?
A. Only red blood cells
B. Only neurons
C. Any type of body cell
D. Only skin cells
#cells #cancercells #cancer #oncology ... Continue to:
@gracefuluniverse.bsky.social#aging #ecotoxicology #oncology
Hexavalent chromium (Cr(VI)) exposure
was consistently associated with
hypermethylation of tumour suppressor genes
(including MLH1 and RAD51),
increased H3K9me2,
and dysregulation of oncogenic microRNAs
including miR-3940-5p
.
academic.oup.com/eep/article/...
@diseaseatlas.bsky.socialBlocking a target is rarely the end; the disease reroutes. Disease Atlas by Euretos maps BRAF in its network on experimental evidence: the signal escapes through MEK and CRAF, and MEK is already drugged, which is why BRAF and MEK are given together in the clinic. #Oncology
@healthcaretoday.bsky.socialIn the first phase of operations, Kai Tak Hospital, Hong Kong’s largest public hospital, will start some clinical services from October, with more rolled out later in the month.
healthcaretoday.com/article/hong...
#HongKong #HealthcareInfrastructure #Oncology #GlobalHealth #Hospitals
@newsramp.comNew research shows tumor microenvironments actively reshape natural killer cells into distinct subsets — some exhausted, some potent memory-like killers. The findings could redefine precision cancer immunotherapy and accelerate next-gen NK cell treatments. #Oncology #Immunotherapy
@newsramp.comTelomir Pharmaceuticals reports Telomir-Zn inhibited growth in human and canine osteosarcoma models at Ohio State University, supporting a potential translational development pathway. The company also advances its FDA-cleared TNBC Phase 1/2 program. #Oncology #Biotech
@onclive.bsky.social🚨BREAKING: The @fda.gov has approved atezolizumab in combination with a fluoropyrimidine and oxaliplatin for the adjuvant treatment of adult and pediatric patients 2 years of age and older with stage III dMMR colon cancer #crcsm #oncology
Read more: www.onclive.com/view/fda-app...
@drtimos.bsky.socialHow to win in #Oncology and #Hematology in 2025
📥 Get a FREE #LucidQuest Report http://dlvr.it/TVqzpq
🚀 Oncp/hema drug development is evolving fast. AI-driven Dx, novel MoAs & outcomes-based pricing are reshaping the landscape.
🏆 Who’s leading? AbbVie, Amgen, AZ, BMS, J&J & Novartis.
@onclive.bsky.social🚨BREAKING🚨: The @fda.gov has approved atezolizumab plus chemo for the adjuvant treatment of adult and pediatric patients 2 years of age and older with stage III mismatch repair–deficient colon cancer. #crcsm #oncology
Full story ➡️: www.onclive.com/view/fda-app...
@themednet.bsky.socialCan't make it to the booth? Start a search: tinyurl.com/45rntv8y
@themednet.bsky.socialCan't make it to the booth? Start a search: tinyurl.com/45rntv8y
@themednet.bsky.socialCan't make it to the booth? Start a search: tinyurl.com/45rntv8y
@onclive.bsky.socialThe @fda.gov granted fast track designation to the PSMA x CD3 T-cell engager VIR-5500 for the treatment of patients with late-line metastatic castration-resistant prostate cancer #pcsm #oncology
Read more: www.onclive.com/view/vir-550...
@arborassays.bsky.socialWhy does NLR fluctuate in breast cancer prognosis? High blood NLR with low urinary H2O2 signals low neutrophil migration and less tumor-killing ROS in tissue.
Read more: www.arborassays.com/breast-cance...
#BreastCancerAwareness #PinkOctober #CancerResearch #Oncology #hydrogenperoxide #prognostics
@onclive.bsky.socialMD.Anderson Cancer Center announced the Texas Lone Star Cervical Cancer Elimination Plan 2027-2032, a five-year roadmap to eliminate cervical cancer in Texas #gynsm #oncology www.onclive.com/view/new-sta...
@onclive.bsky.social
@onclive.bsky.social🗞️ Just in: The phase 3 EXCALIBER-RRMM trial met its second dual primary end point, with iberdomide plus daratumumab/dexamethasone extending PFS vs DVd in patients with R/R multiple myeloma #mmsm #oncology
Read more: www.onclive.com/view/iberdom...
@onclive.bsky.social📰 China’s NMPA approved adjuvant T-DXd for HER2+ early breast cancer and residual invasive disease following neoadjuvant therapy with a taxane and trastuzumab. #bcsm #oncology
Full story ➡️: www.onclive.com/view/china-s...
@onclive.bsky.socialSeptember breast cancer news brought data, approvals, and plenty of expert perspectives. @danafarber.bsky.social @harvardmed.bsky.social @clevelandclinic.bsky.social #BreastCancerBriefing #oncology
Sign up to read a recap of the #bcsm news & insights we reported ➡️: www.onclive.com/view/breast-...